TRPML1
AssetAlso TRPML1 (rare)
Activates TRPML1 to enhance autophagic removal of toxic aggregates and protect neuronal health.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Not known
- 3
- Indications
- 0
- Trials
- 2
- Developers
Indications
3Alzheimer's disease
Preclinical, libratx.com, 10 Oct 2026
Amyotrophic lateral sclerosis
Preclinical, libratx.com, 10 Oct 2026
Parkinson's disease
Preclinical, libratx.com, 10 Oct 2026
In the full profile
- Owner and partners2
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.